拮抗剂-话题@MedSci

#拮抗剂#

223篇内容 | 4337人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1511641, encodeId=547815116412a, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=ADAA 2016：CRHR1受体拮抗剂对PTSD女性患者无效, objectType=article, longId=66101, objectId=3c526610125, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c526610125, replyNumber=0, likeNumber=57, createdTime=2016-04-07, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c526610125, moduleTitle=ADAA 2016：CRHR1受体拮抗剂对PTSD女性患者无效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c526610125)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511640, encodeId=770f151164082, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JACC：组胺H2受体拮抗剂（H2RA）可减少心衰的发生, objectType=article, longId=65701, objectId=7c7a65e01a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c7a65e01a5, replyNumber=0, likeNumber=74, createdTime=2016-03-31, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c7a65e01a5, moduleTitle=JACC：组胺H2受体拮抗剂（H2RA）可减少心衰的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c7a65e01a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511639, encodeId=e3721511639de, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Thorax：长效β受体阻滞剂与长效毒蕈碱受体拮抗剂联合治疗COPD的疗效与安全分析, objectType=article, longId=58515, objectId=c3125851569, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3125851569, replyNumber=0, likeNumber=65, createdTime=2015-11-10, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3125851569, moduleTitle=Thorax：长效β受体阻滞剂与长效毒蕈碱受体拮抗剂联合治疗COPD的疗效与安全分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3125851569)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511638, encodeId=f3951511638fe, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=BMJ：警惕！前列腺特异性α受体拮抗剂可增加男性跌倒及骨折的发生风险, objectType=article, longId=57852, objectId=a24b5e85203, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a24b5e85203, replyNumber=0, likeNumber=83, createdTime=2015-10-28, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a24b5e85203, moduleTitle=BMJ：警惕！前列腺特异性α受体拮抗剂可增加男性跌倒及骨折的发生风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a24b5e85203)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511637, encodeId=a411151163e63, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Cardiol Rev：房颤非维生素K拮抗剂口服抗凝药患者为预防卒中是否应联合抗血小板治疗？, objectType=article, longId=56104, objectId=83865610462, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83865610462, replyNumber=0, likeNumber=51, createdTime=2015-09-13, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83865610462, moduleTitle=Cardiol Rev：房颤非维生素K拮抗剂口服抗凝药患者为预防卒中是否应联合抗血小板治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83865610462)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511636, encodeId=8e02151163674, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=第三代非甾体MR拮抗剂finerenone对慢性心力衰竭和糖尿病性肾病进入III期临床试验阶段, objectType=article, longId=55622, objectId=6995556228c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6995556228c, replyNumber=0, likeNumber=31, createdTime=2015-09-03, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6995556228c, moduleTitle=第三代非甾体MR拮抗剂finerenone对慢性心力衰竭和糖尿病性肾病进入III期临床试验阶段, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6995556228c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511635, encodeId=738f1511635ff, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Stroke：非–维生素K拮抗剂口服抗凝剂治疗的患者的凝血护理点测试（POCT）, objectType=article, longId=54926, objectId=a92f54926a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a92f54926a3, replyNumber=0, likeNumber=51, createdTime=2015-08-18, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a92f54926a3, moduleTitle=Stroke：非–维生素K拮抗剂口服抗凝剂治疗的患者的凝血护理点测试（POCT）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a92f54926a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511634, encodeId=a731151163452, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Anesthesiology：TMEM16A拮抗剂可有效调节气道平滑肌, objectType=article, longId=54803, objectId=963854803bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=963854803bd, replyNumber=0, likeNumber=49, createdTime=2015-08-14, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=963854803bd, moduleTitle=Anesthesiology：TMEM16A拮抗剂可有效调节气道平滑肌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=963854803bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511633, encodeId=435c151163351, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Stroke：非维生素K拮抗剂口服抗凝血药可预防亚洲非瓣膜性房颤患者脑卒中, objectType=article, longId=54306, objectId=ea5e543062a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea5e543062a, replyNumber=0, likeNumber=66, createdTime=2015-08-05, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea5e543062a, moduleTitle=Stroke：非维生素K拮抗剂口服抗凝血药可预防亚洲非瓣膜性房颤患者脑卒中, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea5e543062a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511632, encodeId=bf921511632f7, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JAMA：维生素k拮抗剂治疗静脉血栓，长期or短期疗效, objectType=article, longId=54056, objectId=6dab540565f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6dab540565f, replyNumber=0, likeNumber=78, createdTime=2015-07-29, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6dab540565f, moduleTitle=JAMA：维生素k拮抗剂治疗静脉血栓，长期or短期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6dab540565f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511631, encodeId=d42d1511631f1, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=强生银屑病治疗药IL-23拮抗剂临床IIb期获得成功, objectType=article, longId=53308, objectId=38ea5330848, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38ea5330848, replyNumber=0, likeNumber=34, createdTime=2015-07-15, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38ea5330848, moduleTitle=强生银屑病治疗药IL-23拮抗剂临床IIb期获得成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38ea5330848)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511630, encodeId=edcd151163079, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=BMC Pharmacol Toxicol：CXCR2拮抗剂danirixin可能对嗜中性粒细胞的炎性疾病有效果, objectType=article, longId=52374, objectId=60f9523e41d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60f9523e41d, replyNumber=0, likeNumber=24, createdTime=2015-06-24, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60f9523e41d, moduleTitle=BMC Pharmacol Toxicol：CXCR2拮抗剂danirixin可能对嗜中性粒细胞的炎性疾病有效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60f9523e41d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511629, encodeId=3ba6151162965, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JCEM：新型AMPK激活/mTOR拮抗剂抑制甲状腺癌生长, objectType=article, longId=51290, objectId=452c51290a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=452c51290a7, replyNumber=0, likeNumber=89, createdTime=2015-05-29, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=452c51290a7, moduleTitle=JCEM：新型AMPK激活/mTOR拮抗剂抑制甲状腺癌生长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=452c51290a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511628, encodeId=37ec15116285d, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=NEJM：新型口服抗凝药与VK拮抗剂疗效相当, objectType=article, longId=46031, objectId=f87046031ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f87046031ed, replyNumber=0, likeNumber=68, createdTime=2015-01-25, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f87046031ed, moduleTitle=NEJM：新型口服抗凝药与VK拮抗剂疗效相当, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f87046031ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511627, encodeId=5ae6151162ee7, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JAMA：肿瘤坏死因子拮抗剂与癌症风险升高无关, objectType=article, longId=45780, objectId=760845e80a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=760845e80a1, replyNumber=0, likeNumber=58, createdTime=2015-01-22, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=760845e80a1, moduleTitle=JAMA：肿瘤坏死因子拮抗剂与癌症风险升高无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=760845e80a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511626, encodeId=253915116261c, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Lancet Diab & Endo：刀尖上的舞蹈—盐皮质激素受体拮抗剂在CKD患者中的应用, objectType=article, longId=43635, objectId=0e4e43635a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e4e43635a6, replyNumber=0, likeNumber=58, createdTime=2014-12-07, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e4e43635a6, moduleTitle=Lancet Diab & Endo：刀尖上的舞蹈—盐皮质激素受体拮抗剂在CKD患者中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e4e43635a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511625, encodeId=9aa51511625c7, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=NEJM：依度沙班拮抗剂PER977初步效果良好, objectType=article, longId=42519, objectId=b6d642519a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6d642519a6, replyNumber=0, likeNumber=69, createdTime=2014-11-14, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6d642519a6, moduleTitle=NEJM：依度沙班拮抗剂PER977初步效果良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6d642519a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511624, encodeId=2e901511624e7, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Eur J Anaesthesiol：拮抗残留神经肌肉阻滞作用后患者预后的回顾性调查：Sugammadex组，新斯的明组，不予拮抗剂组, objectType=article, longId=37796, objectId=57f93e796ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57f93e796ef, replyNumber=0, likeNumber=66, createdTime=2014-07-16, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57f93e796ef, moduleTitle=Eur J Anaesthesiol：拮抗残留神经肌肉阻滞作用后患者预后的回顾性调查：Sugammadex组，新斯的明组，不予拮抗剂组, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57f93e796ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511623, encodeId=f0b615116236b, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Pediatr Crit Care Med：IL-1受体拮抗剂阿那白滞素有望治疗危重血液病儿童患者, objectType=article, longId=37761, objectId=41e33e76137, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41e33e76137, replyNumber=0, likeNumber=66, createdTime=2014-07-13, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41e33e76137, moduleTitle=Pediatr Crit Care Med：IL-1受体拮抗剂阿那白滞素有望治疗危重血液病儿童患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41e33e76137)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511622, encodeId=f897151162284, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JACI：TRPV1拮抗剂不能改善慢咳患者的咳嗽症状, objectType=article, longId=37702, objectId=51633e70229, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51633e70229, replyNumber=0, likeNumber=153, createdTime=2014-07-12, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51633e70229, moduleTitle=JACI：TRPV1拮抗剂不能改善慢咳患者的咳嗽症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51633e70229)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

拮抗剂

2020-05-29

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

ADAA 2016：CRHR1受体拮抗剂对PTSD女性患者无效

2016-04-07

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JACC：组胺H2受体拮抗剂（H2RA）可减少心衰的发生

2016-03-31

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Thorax：长效β受体阻滞剂与长效毒蕈碱受体拮抗剂联合治疗COPD的疗效与安全分析

2015-11-10

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

BMJ：警惕！前列腺特异性α受体拮抗剂可增加男性跌倒及骨折的发生风险

2015-10-28

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Cardiol Rev：房颤非维生素K拮抗剂口服抗凝药患者为预防卒中是否应联合抗血小板治疗？

2015-09-13

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

第三代非甾体MR拮抗剂finerenone对慢性心力衰竭和糖尿病性肾病进入III期临床试验阶段

2015-09-03

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Stroke：非–维生素K拮抗剂口服抗凝剂治疗的患者的凝血护理点测试（POCT）

2015-08-18

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Anesthesiology：TMEM16A拮抗剂可有效调节气道平滑肌

2015-08-14

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Stroke：非维生素K拮抗剂口服抗凝血药可预防亚洲非瓣膜性房颤患者脑卒中

2015-08-05

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JAMA：维生素k拮抗剂治疗静脉血栓，长期or短期疗效

2015-07-29

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

强生银屑病治疗药IL-23拮抗剂临床IIb期获得成功

2015-07-15

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

BMC Pharmacol Toxicol：CXCR2拮抗剂danirixin可能对嗜中性粒细胞的炎性疾病有效果

2015-06-24

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JCEM：新型AMPK激活/mTOR拮抗剂抑制甲状腺癌生长

2015-05-29

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

NEJM：新型口服抗凝药与VK拮抗剂疗效相当

2015-01-25

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JAMA：肿瘤坏死因子拮抗剂与癌症风险升高无关

2015-01-22

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Lancet Diab & Endo：刀尖上的舞蹈—盐皮质激素受体拮抗剂在CKD患者中的应用

2014-12-07

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

NEJM：依度沙班拮抗剂PER977初步效果良好

2014-11-14

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Eur J Anaesthesiol：拮抗残留神经肌肉阻滞作用后患者预后的回顾性调查：Sugammadex组，新斯的明组，不予拮抗剂组

2014-07-16

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Pediatr Crit Care Med：IL-1受体拮抗剂阿那白滞素有望治疗危重血液病儿童患者

2014-07-13

爆笑小医 (审核中...)

前往app查看评论内容

#拮抗剂#

JACI：TRPV1拮抗剂不能改善慢咳患者的咳嗽症状

2014-07-12

科室
- - 订阅+
  - 更多科室
工具
服务